Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
lopinavir (Kaletra) (1 trial)
ritonavir (Norvir) (1 trial)
raltegravir (isentress) (1 trial)
tenofovir (viread) (1 trial)
Acquired Immunodeficiency Syndrome (Phase 3)
Communicable Diseases (Phase 3)
HIV Infections (Phase 4)
Infections (Phase 3)
Trials (2 total)
Trial APIs (4 total)